SUBSCRIBE
SUBSCRIBE

Preclinical

Drug Development
Genocea’s ATLAS Platform May Be Game Changer in Cancer Immunotherapy
While the ATLAS platform has the potential to lead to an effective vaccine in itself, its greatest impact in the field of immunotherapy may be that it offers a new way of understanding how a tumor evades the therapy’s boundaries by identifying bad Inhibigens that lead to suppressive, or inhibitory, responses.
January 28, 2021
 · 
3 min read
 · 
Heather McKenzie
Drug Development
2021 Biopharma Update on the Novel Coronavirus: January 26
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for January 26, 2021.
January 26, 2021
 · 
4 min read
 · 
BioSpace Editorial Staff
Drug Development
2021 Biopharma Update on the Novel Coronavirus: January 19
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for January 19, 2021.
January 19, 2021
 · 
6 min read
 · 
BioSpace Editorial Staff
Keitma/Shutterstock
Business
Sanofi Keeps on Rolling With Biond Biologics Partnership
The novel immune checkpoint inhibitor Sanofi deemed worthy of such an investment is BND-22, a humanized IgG4 antagonist antibody targeting the Ig-like transcript 2 (ILT2) receptor, an inhibitory receptor expressed on both innate and adaptive immune cells.
January 12, 2021
 · 
3 min read
 · 
Heather McKenzie
Drug Development
2021 Biopharma Update on the Novel Coronavirus: January 12
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for January 12, 2021.
January 12, 2021
 · 
4 min read
 · 
BioSpace Editorial Staff
Drug Development
2021 Biopharma Update on the Novel Coronavirus: January 5
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for January 5, 2021.
January 4, 2021
 · 
3 min read
 · 
BioSpace Editorial Staff
Drug Development
Biopharma Update on the Novel Coronavirus: December 29
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for December 29, 2020.
December 22, 2020
 · 
2 min read
 · 
BioSpace Editorial Staff
Policy
Biopharma Update on the Novel Coronavirus: December 22
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for December 22, 2020.
December 22, 2020
 · 
4 min read
 · 
BioSpace Editorial Staff
Drug Development
Biopharma Update on the Novel Coronavirus: December 15
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for December 15, 2020.
December 15, 2020
 · 
3 min read
 · 
BioSpace Editorial Staff
Photo Courtesy of Faze Medicines
Business
Biomolecular Condensates Gain More Funding as Faze Snags $81M for ALS & DM1
Cambridge-based Faze Medicines, the biotechnology company that develops therapeutics based on biomolecular condensates, announced today that it has raised $81 million in a Series A round of financing.
December 10, 2020
 · 
3 min read
 · 
Krystle Vermes
Load More
PRESS RELEASES
Press Releases
Derm-Biome’s DB-006 Demonstrates Superior Efficacy in Preclinical Atopic Dermatitis Study: Reduces Itch, Inflammation, and IgE Levels, Outperforms Leading Topical Drugs
June 19, 2026
 · 
2 min read
Press Releases
Odyssey Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
June 18, 2026
 · 
7 min read
Press Releases
Spot Biosystems Launches with $40 Million Financing and World-First Non-Viral Delivery of Full-Length Dystrophin in Animal Models and Human Patients with DMD
June 18, 2026
 · 
6 min read
Press Releases
Acumen Pharmaceuticals Announces Nomination of Two Enhanced Brain Delivery™ (EBD™) Development Candidates for the Treatment of Alzheimer’s Disease
June 16, 2026
 · 
7 min read
Press Releases
Confo Therapeutics Announces Encouraging Preclinical Data for Post-bariatric Hypoglycemia Candidate CFTX-2034 at ENDO 2026
June 15, 2026
 · 
3 min read
Press Releases
Ethyreal Bio Presents First Preclinical Data on ETHY-001 at ENDO 2026, Demonstrating Complete Blockade of Autoantibody Activation of TSHR and Differentiated Activity in TED
June 15, 2026
 · 
5 min read
Press Releases
Telomir Pharmaceuticals Announces Peer-Reviewed Publication in Biomedicine & Pharmacotherapy Demonstrating Restoration of Insulin Sensitivity with Telomir-Zn in a Preclinical Type 2 Diabetes Model
June 15, 2026
 · 
7 min read
Press Releases
Preclinical Data for OPKO Biologics’ OPK8801001 in Acromegaly Presented at ENDO 2026
June 15, 2026
 · 
4 min read
Press Releases
Promising First-in-Patient Results for ACOU085 (INN: Bimokalner) in Cisplatin-Induced Ototoxicity
June 12, 2026
 · 
2 min read
Press Releases
Recludix Pharma to Present Preclinical Asthma and Dermatitis Data for Oral STAT6 Inhibitor REX-8756 at the European Association of Allergy and Clinical Immunology (EAACI) and Revolutionizing Atopic Dermatitis (RAD) Congresses
June 12, 2026
 · 
3 min read
Press Releases
Cogent Biosciences Announces Preclinical Data from Novel JAK2 V617F Inhibitor at the 2026 European Hematology Association (EHA) Congress
June 12, 2026
 · 
4 min read
Press Releases
Applied Biologics Launches Preclinical Development Program Focused on Osteoarthritis and Other Degenerative Diseases
June 11, 2026
 · 
2 min read
Press Releases
JW Pharmaceutical Presents Preclinical Results and Global Development Strategy for DDC-02, a Novel Therapeutic Candidate for Rare Neurodevelopmental Disorders
June 11, 2026
 · 
4 min read
Press Releases
Paratus Sciences Presents Preclinical and Translational Data on PS-1001, a First-in-Class Pan-Inflammasome Inhibitor, at FOCIS 2026
June 11, 2026
 · 
3 min read
Press Releases
Evaxion presents new preclinical data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia
June 11, 2026
 · 
5 min read
Press Releases
HERVolution Therapeutics Demonstrates Preclinical Proof-of-Concept for Insulin Sensitization Immune Therapy in Metabolic Disease and Announces Exclusive License Agreement with the University of Copenhagen
June 10, 2026
 · 
3 min read
Press Releases
Nasus Pharma Announces Positive Results from Preclinical Pharmacokinetic and Safety Study of Intranasal Ondansetron (NS003)
June 9, 2026
 · 
4 min read
Press Releases
insitro Presents New Data Demonstrating Its AI-Discovered MASH Candidate Shows Anti-Fibrotic Signal Beyond Liver-Fat Reduction at the American Diabetes Association 86th Scientific Sessions
June 9, 2026
 · 
6 min read
Press Releases
New CNTY-813 Preclinical Data Demonstrate Durable Glucose Control, Immune Evasion Under Alloimmune Pressure, and Scalable Manufacturing at ADA 2026
June 9, 2026
 · 
11 min read
Press Releases
Septerna to Present Preclinical Characterization of SEP-479, an Oral PTH1R Agonist for Hypoparathyroidism, at 2026 ENDO Annual Meeting
June 8, 2026
 · 
5 min read
Load More